---
title: "Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280179256.md"
description: "Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access"
datetime: "2026-03-23T14:19:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280179256.md)
  - [en](https://longbridge.com/en/news/280179256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280179256.md)
generator: "portal-rs"
---

# Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access

Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access

### Related Stocks

- [VRT.AU](https://longbridge.com/en/quote/VRT.AU.md)
- [IXJ.AU](https://longbridge.com/en/quote/IXJ.AU.md)

## Related News & Research

- [3 healthcare ETFs to own in a choppy stock market](https://longbridge.com/en/news/291834343.md)
- [European patient access to new drugs worsens, pharma lobby says](https://longbridge.com/en/news/290482672.md)
- [Percheron Therapeutics Issues 27.5 Million Unquoted Options Expiring in 2028](https://longbridge.com/en/news/282766254.md)
- [Qoria (FMZNF) Gets a Buy from Canaccord Genuity](https://longbridge.com/en/news/284127081.md)
- [Macquarie Sticks to Their Hold Rating for HealthCo Healthcare & Wellness REIT (HCW)](https://longbridge.com/en/news/281811522.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**